Absent or Hidden? Hyperactivity in Females With ADHD.

Autor: Wettstein R; ADHDcentraal, Amsterdam, The Netherlands.; Amsterdam Public Health, Mental Health, Personalized Medicine, Location Academic Medical Center, The Netherlands.; Amsterdam University Medical Centers, Department of Clinical Pharmacology, Amsterdam, The Netherlands., Navarro Ovando V; ADHDcentraal, Amsterdam, The Netherlands.; Amsterdam Public Health, Mental Health, Personalized Medicine, Location Academic Medical Center, The Netherlands.; Amsterdam University Medical Centers, Department of Clinical Pharmacology, Amsterdam, The Netherlands., Pirgon E; ADHDcentraal, Amsterdam, The Netherlands.; Amsterdam University Medical Centers, Department of Clinical Pharmacology, Amsterdam, The Netherlands., Kroesen J; ADHDcentraal, Amsterdam, The Netherlands., Wettstein K; ADHDcentraal, Amsterdam, The Netherlands., Kroesen H; ADHDcentraal, Amsterdam, The Netherlands., Mathôt R; Amsterdam University Medical Centers, Department of Clinical Pharmacology, Amsterdam, The Netherlands., Dumont G; ADHDcentraal, Amsterdam, The Netherlands.; Amsterdam Public Health, Mental Health, Personalized Medicine, Location Academic Medical Center, The Netherlands.; Amsterdam University Medical Centers, Department of Clinical Pharmacology, Amsterdam, The Netherlands.

Publikováno v: Journal of attention disorders [J Atten Disord] 2024 Oct; Vol. 28 (12), pp. 1589-1597. Date of Electronic Publication: 2024 Aug 19.

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.

Autor: van Huizen A; Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: a.m.vanhuizen@amsterdamumc.nl., Bank P; Department of Hospital Pharmacy & Clinical Pharmacology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands; Department of Hospital Pharmacy, Northwest Clinics, Alkmaar, The Netherlands; Department of Hospital Pharmacy, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands., van der Kraaij G; Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Musters A; Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Busard C; Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Menting S; Department of Dermatology, OLVG, Amsterdam, The Netherlands., Rispens T; Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., de Vries A; Sanquin Diagnostic Services, Sanquin, Amsterdam, The Netherlands., van Doorn M; Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands., Prens E; Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands., Lambert J; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., van den Reek J; Department of Dermatology, Radboud UMC, Radboud University, Nijmegen, The Netherlands., de Jong E; Department of Dermatology, Radboud UMC, Radboud University, Nijmegen, The Netherlands., Mathôt R; Department of Hospital Pharmacy & Clinical Pharmacology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Spuls P; Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2024 Apr; Vol. 144 (4), pp. 794-801.e6. Date of Electronic Publication: 2023 Nov 20.

PB0657 Is Implementation of Pharmacokinetic-Guided Dosing of Factor Replacement Therapy in Bleeding Disorders on TARGET? A Scoping Review to Map Barriers and Facilitators

Autor: Goedhart, T., Janssen, A., Mussert, C., Mathôt, R., Cnossen, M.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2

PB0464 Smaller Nadroparin Dose Reductions Required for Patients with Renal Impairment: A Multicenter Study

Autor: van Uden, R., Jaspers, T., Meijer, K., van Stralen, K., Maat, B., Khorsand, N., van Onzenoort, H., Swart, E., Huls, H., Mathôt, R., van den Bemt, P., Becker, M.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.